Brief: Benitec Biopharma To Regain Compliance With Nasda Bid Price Rule
March 8 (Reuters) - Benitec Biopharma Inc BNTC.O :
* BENITEC BIOPHARMA - ON MARCH 7, NASDAQ NOTIFIED CO WAS
ELIGIBLE
UNTIL SEPTEMBER 5, 2023, TO REGAIN COMPLIANCE WITH THE BID PRICE
RULE
Source text for Eikon: ID:
Further company coverage: BNTC.O
((Reuters.Briefs@thomsonreuters.com;))